{"id":132388,"date":"2026-11-09T08:28:21","date_gmt":"2026-11-09T02:58:21","guid":{"rendered":"https:\/\/vajiramandravi.com\/current-affairs\/?p=132388"},"modified":"2026-11-10T12:36:29","modified_gmt":"2026-11-10T07:06:29","slug":"daily-editorial-analysis-9-november-2026","status":"publish","type":"post","link":"https:\/\/vajiramandravi.com\/current-affairs\/daily-editorial-analysis-9-november-2026\/","title":{"rendered":"Daily Editorial Analysis 9 November 2026"},"content":{"rendered":"<h2><strong>Demonetisation and the Health Costs of Cash Shortages <\/strong><\/h2>\n<h3><strong>Context<\/strong><\/h3>\n<ul>\n<li>India\u2019s <strong>demonetisation of November 8, 2016<\/strong>, withdrew \u20b9500 and \u20b91,000 notes, representing approximately 86% of currency in circulation by value, with only four hours\u2019 notice.<\/li>\n<li>The objectives included <strong>curbing black money, counterfeit currency<\/strong> and promoting digital payments.<\/li>\n<li>However, the exercise created a massive liquidity shock in a cash-dependent economy.<\/li>\n<li>Although nearly <strong>3% of demonetised currency returned to the banking system<\/strong>, the temporary cash shortage disrupted economic activities and essential consumption.<\/li>\n<\/ul>\n<h3><strong>Demonetisation Effect on Medicine Consumption<\/strong><\/h3>\n<ul>\n<li>\n<h4><strong>Understanding Differences in Medicine Consumption<\/strong><\/h4>\n<ul>\n<li>Research published in the Journal of Economics and Management Strategy examines pharmaceutical consumption during demonetisation using the All India Organisation of <strong>Chemists and Druggists (AIOCD) database.<\/strong><\/li>\n<li>It covers monthly sales across 805 pharmaceutical firms, 31 regions and 18 illness categories.<\/li>\n<li>The study distinguishes between:<\/li>\n<li><strong>Chronic medicines<\/strong>, which are purchased regularly for long-term illnesses, allowing consumers to compare prices and identify affordable alternatives.<\/li>\n<li><strong>Acute medicines,<\/strong> which are required for sudden illnesses such as infections, pain and gastrointestinal problems, leaving little opportunity to postpone purchases or search for alternatives.<\/li>\n<li>This difference is explained through search costs, the time and resources required to identify suitable products and compare prices.<\/li>\n<li>Consumers purchasing chronic medicines can plan their expenditure, whereas acute medicine purchases are generally urgent and unanticipated.<\/li>\n<\/ul>\n<\/li>\n<li>\n<h4><strong>Evidence of Reduced Medicine Consumption<\/strong><\/h4>\n<ul>\n<li>Using a difference-in-differences research design, the study found that acute medicine sales volume declined by approximately 3.6%, while <strong>sales value fell by 3.1% relative to chronic medicines.<\/strong><\/li>\n<li>The decline was not caused by products disappearing from the market or increasing prices.<\/li>\n<li>The number of unique products and the <strong>interquartile range<\/strong> of prices remained unchanged.<\/li>\n<li>This indicates an intensive-margin contraction, meaning consumers purchased smaller quantities of available medicines.<\/li>\n<li><strong>Prescription data from IQVIA<\/strong> and disease-outbreak information from the Integrated Disease Surveillance Programme (IDSP) also revealed no significant changes in prescription trends or acute disease outbreaks.<\/li>\n<li>Thus, the <strong>decline was associated with cash constraints<\/strong> rather than reduced medical requirements.<\/li>\n<\/ul>\n<\/li>\n<li>\n<h4><strong>Healthcare Vulnerability in a Cash-Dependent Economy<\/strong><\/h4>\n<ul>\n<li>India&#8217;s substantial <strong>out-of-pocket healthcare expenditure<\/strong> makes households particularly vulnerable to sudden financial disruptions.<\/li>\n<li>Unlike insured populations in developed economies, <strong>many Indian families directly finance medicines<\/strong> and treatment.<\/li>\n<li>Consequently, medicines may remain available and prices stable, yet patients may be unable to purchase them because of inadequate cash.<\/li>\n<li>Therefore, market availability does not guarantee<strong> actual healthcare access.<\/strong><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>Lessons for the Future<\/strong><\/h3>\n<ul>\n<li>\n<h4><strong>Assessing the Distributional Consequences of Monetary Policy<\/strong><\/h4>\n<ul>\n<li>Currency replacement exercises may pursue <strong>legitimate objectives<\/strong>, including reducing counterfeit currency, improving tax compliance and encouraging digital transactions.<\/li>\n<li>However, policymakers must evaluate their <strong>wider social consequences.<\/strong><\/li>\n<li>Research by Das and other economists indicates that demonetisation generated only modest tax gains.<\/li>\n<li>Moreover, the return of almost all withdrawn currency raises questions about the <strong>extent of its effectiveness<\/strong> in achieving its stated objectives.<\/li>\n<li>The pharmaceutical findings demonstrate that economic disruptions affect different categories of consumers unequally.<\/li>\n<li>Therefore, distributional consequences must be assessed alongside monetary and administrative objectives.<\/li>\n<\/ul>\n<\/li>\n<li>\n<h4><strong>Strengthening Public Health Infrastructure<\/strong><\/h4>\n<ul>\n<li>The study identifies public health infrastructure as an important buffer against liquidity shocks.<\/li>\n<li>Regions with weaker public healthcare facilities experienced larger declines in acute medicine consumption.<\/li>\n<li>Several initiatives can strengthen healthcare resilience:\n<ul>\n<li><strong>Pradhan Mantri Bhartiya Janaushadhi Kendras<\/strong> improve access to affordable generic medicines.<\/li>\n<li><a href=\"https:\/\/vajiramandravi.com\/upsc-exam\/ayushman-bharat-pradhan-mantri-jan-arogya-yojana\/\" target=\"_blank\"><strong>AB-PMJAY<\/strong><\/a> provides financial protection against eligible hospitalisation expenses.<\/li>\n<li>UPI-based digital payments facilitate cashless transactions at pharmacies.<\/li>\n<li>However, digital payments cannot completely replace cash because of inadequate connectivity, limited digital literacy and unequal banking access.<\/li>\n<\/ul>\n<\/li>\n<li>Future currency operations should incorporate health-sector safeguards, including <strong>emergency credit facilities<\/strong> for pharmacies, uninterrupted medicine supplies and accessible digital payment systems.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>The Way Forward: Building Evidence-Based Public Policy<\/strong><\/h3>\n<ul>\n<li>Although <strong>pharmaceutical sales data<\/strong> reveal changes in medicine consumption, they do not establish the direct consequences for household health outcomes.<\/li>\n<li>Reduced medicine purchases may lead to <strong>delayed treatment<\/strong>, worsening illnesses and additional medical complications.<\/li>\n<li>India therefore needs <strong>integrated consumption-health databases<\/strong> linking household expenditure, prescriptions, medicine purchases and health outcomes.<\/li>\n<li>Additionally, pre-registered evaluation protocols should accompany large-scale economic interventions.<\/li>\n<li>These would establish measurable indicators, identify vulnerable populations and facilitate independent assessments of policy consequences.<\/li>\n<li><strong>Improved data systems<\/strong> would help governments anticipate unintended effects and introduce appropriate safeguards before implementing disruptive economic measures.<\/li>\n<\/ul>\n<h3><strong>Conclusion<\/strong><\/h3>\n<ul>\n<li>A decade after demonetisation, its experience offers important lessons for monetary policy and public health.<\/li>\n<li>Although digital payment adoption accelerated and <strong>counterfeit currency<\/strong> was withdrawn, sudden cash shortages also disrupted essential consumption.<\/li>\n<li>For households dependent on <strong>out-of-pocket healthcare expenditure<\/strong>, financial disruptions can result in delayed treatment and reduced access to essential medicines.<\/li>\n<li>Future economic interventions must balance financial objectives with social protection.<\/li>\n<li>Ultimately, economic reforms must<strong> protect essential consumption<\/strong>, ensuring that financial disruptions do not compromise access to medicines and basic healthcare, particularly among vulnerable populations.<\/li>\n<\/ul>\n<h3><strong>Demonetisation and the Health Costs of Cash Shortages FAQs<\/strong><\/h3>\n<p><strong>Q1.<\/strong> What was the primary objective of demonetisation in 2016?<\/p>\n<p><strong>Ans.<\/strong> It aimed to curb black money, counterfeit currency and promote digital payments.<\/p>\n<p><strong>Q2.<\/strong> How much demonetised currency returned to the banking system?<\/p>\n<p><strong>Ans.<\/strong> Approximately 99.3% of the demonetised currency returned to the banking system.<\/p>\n<p><strong>Q3.<\/strong> Why were acute medicines more affected than chronic medicines?<\/p>\n<p><strong>Ans.<\/strong> Acute medicines require urgent purchases, leaving consumers little time to search for affordable alternatives.<\/p>\n<p><strong>Q4.<\/strong> What was the impact of demonetisation on acute medicine sales?<\/p>\n<p><strong>Ans.<\/strong> Acute medicine sales volume declined by approximately 3.6% relative to chronic medicines.<\/p>\n<p><strong>Q5.<\/strong> What is the major policy lesson from the study?<\/p>\n<p><strong>Ans.<\/strong> Economic interventions must protect essential healthcare consumption by strengthening public health infrastructure and ensuring uninterrupted access to medicines.<\/p>\n<p><strong>Source: <a href=\"https:\/\/www.thehindu.com\/opinion\/op-ed\/demonetisation-and-the-health-costs-of-cash-shortages\/article71675256.ece\" target=\"_blank\" rel=\"nofollow noopener\">The Hindu<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Daily Editorial Analysis 9 November by Vajiram &#038; Ravi covers key editorials from The Hindu &#038; Indian Express with UPSC-focused insights and relevance.<\/p>\n","protected":false},"author":34,"featured_media":86373,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[138],"tags":[141,882,909],"class_list":["post-132388","post","type-post","status-publish","format-standard","has-post-thumbnail","category-daily-editorial-analysis","tag-daily-editorial-analysis","tag-the-hindu-editorial-analysis","tag-the-indian-express-analysis","no-featured-image-padding"],"acf":[],"_links":{"self":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/132388","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/comments?post=132388"}],"version-history":[{"count":4,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/132388\/revisions"}],"predecessor-version":[{"id":132460,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/132388\/revisions\/132460"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media\/86373"}],"wp:attachment":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media?parent=132388"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/categories?post=132388"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/tags?post=132388"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}